YouTube - Faces of Metastatic Breast Cancer
Links shared publicly online about this topic.
- 805total visits
YouTube - Faces of Metastatic Breast Cancer
View full resource at youtube.com
Tags: Cancer, Breast Cancer, Metastatic Breast Cancer, Women's Health, Genentech
Most Recently Shared on October 13, 2011 at 3:15 pm By:
Watch the Faces of Metastatic Breast Cancer video from http://t.co/WmkvZ5qO: http://t.co/nueIhGei We need to do more! #MBC #BCSM
Also Shared By:
MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer
news-medical.net — “Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced that investigators at The University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology have initiated a phase 1/2 study combining Syndax's lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).” View full resource at news-medical.net
Most Recently Shared on April 9, 2012 at 5:48 pm By:
Lung Cancer News: MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastati... http://t.co/4NRLzStn
YouTube - Broadcast Yourself.
youtube.com — “Share your videos with friends, family, and the world” View full resource at youtube.com
Most Recently Shared on March 30, 2012 at 5:25 pm By:
RT @talkabouthealth: What does it mean if the breast cancer is non-invasive? Grt video of @DrAttai! http://t.co/9R9tqKaQ #bcsm #cancer
Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS)
oncologytube.com — “Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS): Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS)....” View full resource at oncologytube.com
Most Recently Shared on March 27, 2012 at 11:00 pm By:
In this #video, Clifford A. Hudis, MD talks about the value of progression-free survival - via @oncologytube http://t.co/4NwbT48r
Percutaneous cryoablation freezes and destroys breast cancer tumors
news-medical.net — “Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation.” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 7:43 pm By:
Breast Cancer News: Percutaneous cryoablation freezes and destroys breast cancer tumors: Individuals fighting me... http://t.co/5d5vB0Nn
Cryoablation therapy spot-freezes breast cancer tumors
eurekalert.org — “Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation. The cancer treatment could potentially be used as a last line of defense to halt individual spots of remaining metastatic disease by freezing and destroying tumors.” View full resource at eurekalert.org
Most Recently Shared on March 26, 2012 at 4:42 pm By:
Cryoablation therapy spot-freezes breast cancer tumors: ( Society of Interventional Radiology ) Individuals figh... http://t.co/jEJLB0xd
Cryoablation therapy spot-freezes breast cancer tumors
medicalxpress.com — “Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation. The cancer treatment could potentially be used as a last line of defense to halt individual spots of remaining metastatic ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 1:35 pm By:
Cryoablation therapy spot-freezes breast cancer tumors http://t.co/grrIuLWP
CTCs vs Serum Tumor Markers in Metastatic Breast Cancer - QualityPoint Technologies
qualitypointtech.net — “Is the prognostic value of CTCs independent from that of serum tumor markers? Annals of Oncology” View full resource at qualitypointtech.net
Most Recently Shared on March 26, 2012 at 1:00 pm By:
CTCs vs Serum Tumor Markers in Metastatic Breast Cancer: Is the prognostic value of CTCs independent from that of ... http://t.co/caK8EvH8
If cancer is found in one breast of a young women, is a bilateral mastectomy ever recommended? - YouTube
youtube.com — “Dr. Deanna Attai shares if a bilateral mastectomy is ever recommended for a woman who has breast cancer in one breast. For more information on this subject, ...” View full resource at youtube.com
Most Recently Shared on March 26, 2012 at 2:31 am By:
If cancer is found in one breast of a young women, is a bilateral mastectomy ever recommended? http://t.co/ReGcBJIK
Molecular Cancer | Abstract | c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
molecular-cancer.com — “The c-Myb transcription factor is essential for the maintenance of stem-progenitor cells in bone marrow, colon epithelia, and neurogenic niches. c-Myb malfunction contributes to several types of malignancies including breast cancer. However, the function of c-Myb in the metastatic spread of breast tumors remains unexplored. In this study, we report a novel role of c-Myb in the control of specific proteases that regulate the matrix-dependent invasion of breast cancer cells.” View full resource at molecular-cancer.com
Most Recently Shared on March 24, 2012 at 1:16 pm By:
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer ... http://t.co/mwz1IUbm
make metastatic breast cancer matter « time to consider the lilies
timetoconsiderthelilies.wordpress.com — “make metastatic breast cancer matter « time to consider the lilies” View full resource at timetoconsiderthelilies.wordpress.com
Most Recently Shared on March 24, 2012 at 12:01 pm By:
Excellent post - make metastatic breast cancer matter http://t.co/TGQ4WVvm via @yvonnewatterson #bcsm
Oncology News - A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer |3985513
mdlinx.com — “Oncology Medical Article: A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 5:09 am By:
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefit... http://t.co/jdwD5w6i #oncology
About Morgan Welch Inflammatory Breast Cancer Research Program and Clinic at MD Anderson - YouTube
youtube.com — “MD Anderson Cancer Center has the largest inflammatory breast cancer clinic. Our mission is to reduce the suffering of IBC patients through translational res...” View full resource at youtube.com
Most Recently Shared on March 22, 2012 at 10:46 pm By:
Grt video on information about inflammatory #breastcancer from @teamoncology #ThinkIBC http://t.co/mM4EMCHH #bcsm
Oncology News - US Food and Drug Administration Approval Overview in Metastatic Breast Cancer |3989528
mdlinx.com — “Oncology Medical Article: US Food and Drug Administration Approval Overview in Metastatic Breast Cancer” View full resource at mdlinx.com
Most Recently Shared on March 22, 2012 at 5:46 pm By:
US Food and Drug Administration Approval Overview in Metastatic Breast Cancer: Journal of Clinical Oncology http://t.co/3ztw5vqr #oncology
Rachel Cheetham Moro on Vimeo
vimeo.com — “Rachel Cheetham Moro died on 6 February 2012 from metastatic breast cancer. She was 41. She will be greatly missed by her beloved husband Anthony, her family, her friends, her dog and the thousands of people who read her sharp, angry and witty words...” View full resource at vimeo.com
Most Recently Shared on March 22, 2012 at 2:03 pm By:
RT @PinkRibbonBlues Film by @Being_Sarah abt Rachel Cheetham Moro @ccchronicles. http://t.co/FY2Cn2Lq cc: @BCAction @CJMeta #bcsm
Oncology News - Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells |3986779
mdlinx.com — “Oncology Medical Article: Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells” View full resource at mdlinx.com
Most Recently Shared on March 21, 2012 at 4:25 pm By:
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in me... http://t.co/SXWBWVsv #oncology
Advertisement




Genentech
@genentechnews
Thanks to everyone who helped raise $20K in support of metastatic #breastcancer by watching #FacesofMBC http://tiny.cc/Faces8
1 year ago...